 |
|
The Time Course Changes in Bone Metabolic Markers after Administering the Anti-Receptor Activator of Nuclear Factor-Kappa B Ligand Antibody and Drug Compliance among Patients with Osteoporosis
Kazuhide Inage, Sumihisa Orita, Kazuyo Yamauchi, Yoshihiro Sakuma, Go Kubota, Yasuhiro Oikawa, Takeshi Sainoh, Jun Sato, Kazuki Fujimoto, Yasuhiro Shiga, Kazuhisa Takahashi, Seiji Ohtori
Asian Spine J. 2015;9(3):338-343. Published online 2015 Jun 8 DOI: https://doi.org/10.4184/asj.2015.9.3.338
|
|
Citations to this article as recorded by
 Different patterns of change in bone turnover markers during treatment with bone-modifying agents for breast cancer patients with bone metastases
Arisa Nishimukai, Tomoko Higuchi, Hiromi Ozawa, Ayako Yanai, Yoshimasa Miyagawa, Keiko Murase, Michiko Imamura, Yuichi Takatsuka, Yasuo Miyoshi
Breast Cancer.2017; 24(2): 245. CrossRef Pathomechanisms and management of osteoporotic pain with no traumatic evidence
Sumihisa Orita, Kazuhide Inage, Miyako Suzuki, Kazuki Fujimoto, Kazuyo Yamauchi, Junichi Nakamura, Yusuke Matsuura, Takeo Furuya, Masao Koda, Kazuhisa Takahashi, Seiji Ohtori
Spine Surgery and Related Research.2017; 1(3): 121. CrossRef The effects of switching daily teriparatide to oral bisphosphonates or denosumab in patients with primary osteoporosis
Kosuke Ebina, Jun Hashimoto, Masafumi Kashii, Makoto Hirao, Shoichi Kaneshiro, Takaaki Noguchi, Yasunori Tsukamoto, Hideki Yoshikawa
Journal of Bone and Mineral Metabolism.2017; 35(1): 91. CrossRef
|